BioGend Therapeutics Co., Ltd. (TPEX:6733)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.45
-0.05 (-0.18%)
May 8, 2025, 2:31 PM CST

BioGend Therapeutics Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2016 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Market Capitalization
3,5414,1814,7082,2472,7573,574
Upgrade
Market Cap Growth
-15.96%-11.18%109.50%-18.50%-22.86%46.27%
Upgrade
Enterprise Value
2,9913,5583,9901,7202,0633,039
Upgrade
Last Close Price
28.5033.6538.2521.8026.4038.34
Upgrade
PS Ratio
19.7224.9442.8371.46297.472565.83
Upgrade
PB Ratio
4.364.944.923.072.925.07
Upgrade
P/TBV Ratio
5.326.096.094.734.535.93
Upgrade
EV/Sales Ratio
16.6521.2236.3054.70222.542181.48
Upgrade
Debt / Equity Ratio
0.010.010.010.020.01-
Upgrade
Asset Turnover
0.190.170.120.030.010.00
Upgrade
Inventory Turnover
2.672.291.891.240.640.10
Upgrade
Quick Ratio
23.2821.0616.9016.7328.5829.27
Upgrade
Current Ratio
25.1221.6017.3217.0129.2429.92
Upgrade
Return on Equity (ROE)
-16.02%-13.30%-19.07%-24.54%-17.51%-22.51%
Upgrade
Return on Assets (ROA)
-9.58%-7.78%-11.79%-14.85%-11.74%-12.53%
Upgrade
Return on Capital (ROIC)
-10.13%-8.37%-12.85%-16.17%-12.43%-12.91%
Upgrade
Earnings Yield
-3.92%-2.79%-3.32%-8.21%-5.02%-4.07%
Upgrade
FCF Yield
-2.71%-2.38%-3.50%-8.32%-4.99%-3.28%
Upgrade
Buyback Yield / Dilution
-0.27%-2.32%-16.69%-1.77%-15.90%-7.56%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.